|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/09/12 Biolase, Inc 10-Q 9/30/12 62:4.8M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 438K
2: EX-31.1 Certification of Chief Executive Officer Pursuant HTML 26K
to Rule 13A-14 and Rule 15D-14
3: EX-31.2 Certification of Chief Financial Officer Pursuant HTML 26K
to Rule 13A-14 and Rule 15D-14
4: EX-32.1 Certification of Chief Executive Officer Pursuant HTML 21K
to 18 U.S.C. 1350
5: EX-32.2 Certification of Chief Financial Officer Pursuant HTML 21K
to 18 U.S.C. 1350
42: R1 Document and Entity Information HTML 41K
31: R2 Consolidated Balance Sheets HTML 141K
40: R3 Consolidated Balance Sheets (Parenthetical) HTML 49K
44: R4 Consolidated Statements of Comprehensive Loss HTML 111K
57: R5 Consolidated Statements of Cash Flows HTML 155K
34: R6 Basis of Presentation HTML 43K
39: R7 Recent Accounting Pronouncements HTML 28K
28: R8 Stock-Based Awards and Per Share Information HTML 92K
20: R9 Inventory HTML 28K
58: R10 Property, Plant, and Equipment HTML 35K
46: R11 Intangible Assets and Goodwill HTML 47K
45: R12 Accrued Liabilities and Deferred Revenue HTML 56K
50: R13 Lines of Credit and Other Borrowings HTML 31K
51: R14 Commitments and Contingencies HTML 28K
49: R15 Segment Information HTML 37K
52: R16 Concentrations HTML 24K
41: R17 Income Taxes HTML 25K
43: R18 Non-Recurring Event HTML 22K
48: R19 Basis of Presentation (Policies) HTML 110K
62: R20 Stock-Based Awards and Per Share Information HTML 87K
(Tables)
54: R21 Inventory (Tables) HTML 26K
36: R22 Property, Plant, and Equipment (Tables) HTML 32K
47: R23 Intangible Assets and Goodwill (Tables) HTML 41K
38: R24 Accrued Liabilities and Deferred Revenue (Tables) HTML 57K
16: R25 Segment Information (Tables) HTML 30K
55: R26 BASIS OF PRESENTATION - Additional Information HTML 52K
(Detail)
59: R27 STOCK-BASED AWARDS AND PER SHARE INFORMATION - HTML 114K
Additional Information (Detail)
24: R28 STOCK-BASED AWARDS AND PER SHARE INFORMATION - HTML 30K
Classification of Compensation Expense Associated
with Share-based Payments (Detail)
23: R29 STOCK-BASED AWARDS AND PER SHARE INFORMATION - HTML 32K
Assumptions Used in Estimating Fair Value of Stock
Options Granted (Detail)
26: R30 STOCK-BASED AWARDS AND PER SHARE INFORMATION - HTML 65K
Summary of Option Activity under Stock Option
Plans (Detail)
27: R31 STOCK-BASED AWARDS AND PER SHARE INFORMATION - HTML 38K
Cash Proceeds Along with Fair Value Disclosures
Related to Grants, Exercises and Vesting Options
(Detail)
29: R32 STOCK-BASED AWARDS AND PER SHARE INFORMATION - HTML 37K
Stock Repurchase Activities (Detail)
15: R33 INVENTORY - Inventories (Detail) HTML 31K
53: R34 INVENTORY - Additional Information (Detail) HTML 26K
35: R35 PROPERTY, PLANT, AND EQUIPMENT - Summary of HTML 37K
Property, Plant and Equipment (Detail)
37: R36 PROPERTY, PLANT, AND EQUIPMENT - Additional HTML 42K
Information (Detail)
18: R37 INTANGIBLE ASSETS AND GOODWILL - Additional HTML 24K
Information (Detail)
61: R38 INTANGIBLE ASSETS AND GOODWILL - Summary of HTML 48K
Intangible Assets, Related Accumulated
Amortization and Goodwill (Detail)
12: R39 ACCRUED LIABILITIES AND DEFERRED REVENUE - HTML 51K
Components of Accrued Liabilities (Detail)
30: R40 ACCRUED LIABILITIES AND DEFERRED REVENUE - Changes HTML 38K
in Initial Product Warranty Accrual and Expenses
Under Initial and Extended Warranties (Detail)
56: R41 ACCRUED LIABILITIES AND DEFERRED REVENUE - Summary HTML 40K
of Deferred Revenue (Detail)
17: R42 ACCRUED LIABILITIES AND DEFERRED REVENUE - HTML 26K
Additional Information (Detail)
22: R43 LINES OF CREDIT AND OTHER BORROWINGS - Additional HTML 118K
Information (Detail)
25: R44 SEGMENT INFORMATION - Additional Information HTML 31K
(Detail)
32: R45 SEGMENT INFORMATION - Summary of Net Revenue by HTML 25K
Geographic Location (Detail)
14: R46 CONCENTRATIONS - Additional Information (Detail) HTML 37K
19: R47 INCOME TAXES - Additional Information (Detail) HTML 23K
13: R48 NON-RECURRING EVENT - Additional Information HTML 36K
(Detail)
60: XML IDEA XML File -- Filing Summary XML 94K
21: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 571K
6: EX-101.INS XBRL Instance -- biol-20120930 XML 973K
8: EX-101.CAL XBRL Calculations -- biol-20120930_cal XML 157K
9: EX-101.DEF XBRL Definitions -- biol-20120930_def XML 734K
10: EX-101.LAB XBRL Labels -- biol-20120930_lab XML 1.11M
11: EX-101.PRE XBRL Presentations -- biol-20120930_pre XML 829K
7: EX-101.SCH XBRL Schema -- biol-20120930 XSD 167K
33: ZIP XBRL Zipped Folder -- 0001193125-12-463502-xbrl Zip 132K
| CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14 AND RULE 15D-14 |
EXHIBIT 31.2
CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Frederick D. Furry, certify that:
1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2012 of BIOLASE, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
| a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
| b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
| d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
| a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: November 9, 2012 | By: | |||||
| Frederick D. Furry | ||||||
| Chief Financial Officer (Principal Financial and Accounting Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/9/12 | None on these Dates | ||
| For Period end: | 9/30/12 | |||
| List all Filings | ||||